Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
May 08 2019 - 6:04PM
Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX:
AEZS) announced today at its annual and special
shareholders’ meeting held on May 8, 2019, that the individuals
noted below were elected as directors of the Company. The report on
proxies provided by the Company’s transfer agent indicated the
following:
Name of Nominee |
Votes For |
% |
Votes Withheld |
% |
Carolyn Egbert |
1,867,049 |
91.19 |
180,324 |
8.81 |
Gérard Limoges |
1,861,389 |
90.92 |
185,984 |
9.08 |
Robin Smith Hoke |
1,864,981 |
91.09 |
182,392 |
8.91 |
Brent Norton |
1,861,563 |
90.92 |
185,810 |
9.08 |
Jonathan Pollack |
1,860,317 |
90.86 |
187,056 |
9.14 |
The Company would like to extend its sincere
thanks and best wishes to Juergen Ernst, who has served on the
board of directors since 2005.
The Company reports the re-appointment of
PricewaterhouseCoopers LLP as the Company's independent
auditor.
The Company’s shareholders approved an ordinary
resolution approving the amended and restated shareholder rights
plan.
Further, the Company passed a special resolution
to amend the articles of the corporation to change the province in
which its registered office is situated from Quebec to Ontario.
For full voting details please see the voting
results of Aeterna Zentaris Inc. as filed on SEDAR at
www.sedar.com and EDGAR at www.sec.gov.
About Aeterna Zentaris
Inc.
Aeterna Zentaris Inc. is a specialty
biopharmaceutical company focused on commercializing novel
pharmaceutical therapies, principally through out-licensing
arrangements. Aeterna Zentaris is a party to a license and
assignment agreement with Novo Nordisk A/S to carry out
development, manufacturing, registration and commercialization of
Macrilen™ (macimorelin) in the United States and Canada. For more
information, visit www.zentaris.com.
Contacts:
Aeterna Zentaris Inc.Leslie AuldChief Financial
OfficerIR@aezsinc.com (843) 900-3211
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Sep 2023 to Sep 2024